Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon.

Totura AL, Baric RS.

Curr Opin Virol. 2012 Jun;2(3):264-75. doi: 10.1016/j.coviro.2012.04.004. Epub 2012 May 7. Review.

PMID:
22572391
2.

Coronavirus virulence genes with main focus on SARS-CoV envelope gene.

DeDiego ML, Nieto-Torres JL, Jimenez-Guardeño JM, Regla-Nava JA, Castaño-Rodriguez C, Fernandez-Delgado R, Usera F, Enjuanes L.

Virus Res. 2014 Dec 19;194:124-37. doi: 10.1016/j.virusres.2014.07.024. Epub 2014 Aug 2. Review.

3.

Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.

Totura AL, Whitmore A, Agnihothram S, Schäfer A, Katze MG, Heise MT, Baric RS.

MBio. 2015 May 26;6(3):e00638-15. doi: 10.1128/mBio.00638-15.

4.

The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection.

Fehr AR, Channappanavar R, Jankevicius G, Fett C, Zhao J, Athmer J, Meyerholz DK, Ahel I, Perlman S.

MBio. 2016 Dec 13;7(6). pii: e01721-16. doi: 10.1128/mBio.01721-16.

5.

Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model.

Cameron MJ, Kelvin AA, Leon AJ, Cameron CM, Ran L, Xu L, Chu YK, Danesh A, Fang Y, Li Q, Anderson A, Couch RC, Paquette SG, Fomukong NG, Kistner O, Lauchart M, Rowe T, Harrod KS, Jonsson CB, Kelvin DJ.

PLoS One. 2012;7(9):e45842. doi: 10.1371/journal.pone.0045842. Epub 2012 Sep 24.

6.

Bat severe acute respiratory syndrome-like coronavirus ORF3b homologues display different interferon antagonist activities.

Zhou P, Li H, Wang H, Wang LF, Shi Z.

J Gen Virol. 2012 Feb;93(Pt 2):275-81. doi: 10.1099/vir.0.033589-0. Epub 2011 Oct 19.

PMID:
22012463
7.

SARS coronavirus and innate immunity.

Frieman M, Heise M, Baric R.

Virus Res. 2008 Apr;133(1):101-12. Epub 2007 Apr 23. Review.

8.

Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques.

de Lang A, Baas T, Teal T, Leijten LM, Rain B, Osterhaus AD, Haagmans BL, Katze MG.

PLoS Pathog. 2007 Aug 10;3(8):e112.

9.

The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.

Hu Y, Li W, Gao T, Cui Y, Jin Y, Li P, Ma Q, Liu X, Cao C.

J Virol. 2017 Mar 29;91(8). pii: e02143-16. doi: 10.1128/JVI.02143-16. Print 2017 Apr 15.

10.

Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus.

Devaraj SG, Wang N, Chen Z, Chen Z, Tseng M, Barretto N, Lin R, Peters CJ, Tseng CT, Baker SC, Li K.

J Biol Chem. 2007 Nov 2;282(44):32208-21. Epub 2007 Aug 30.

11.
12.

Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response.

Kindler E, Thiel V, Weber F.

Adv Virus Res. 2016;96:219-243. doi: 10.1016/bs.aivir.2016.08.006. Epub 2016 Sep 9. Review.

PMID:
27712625
13.

Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses.

Menachery VD, Eisfeld AJ, Schäfer A, Josset L, Sims AC, Proll S, Fan S, Li C, Neumann G, Tilton SC, Chang J, Gralinski LE, Long C, Green R, Williams CM, Weiss J, Matzke MM, Webb-Robertson BJ, Schepmoes AA, Shukla AK, Metz TO, Smith RD, Waters KM, Katze MG, Kawaoka Y, Baric RS.

MBio. 2014 May 20;5(3):e01174-14. doi: 10.1128/mBio.01174-14.

14.

MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.

Sheahan T, Morrison TE, Funkhouser W, Uematsu S, Akira S, Baric RS, Heise MT.

PLoS Pathog. 2008 Dec;4(12):e1000240. doi: 10.1371/journal.ppat.1000240. Epub 2008 Dec 12.

15.

Interferon interplay helps tissue cells to cope with SARS-coronavirus infection.

Kuri T, Weber F.

Virulence. 2010 Jul-Aug;1(4):273-5. doi: 10.4161/viru.1.4.11465.

PMID:
21178452
16.

Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.

Sui J, Deming M, Rockx B, Liddington RC, Zhu QK, Baric RS, Marasco WA.

J Virol. 2014 Dec;88(23):13769-80. doi: 10.1128/JVI.02232-14. Epub 2014 Sep 17.

17.

SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome.

Shi CS, Qi HY, Boularan C, Huang NN, Abu-Asab M, Shelhamer JH, Kehrl JH.

J Immunol. 2014 Sep 15;193(6):3080-9. doi: 10.4049/jimmunol.1303196. Epub 2014 Aug 18.

18.

SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.

Frieman MB, Chen J, Morrison TE, Whitmore A, Funkhouser W, Ward JM, Lamirande EW, Roberts A, Heise M, Subbarao K, Baric RS.

PLoS Pathog. 2010 Apr 8;6(4):e1000849. doi: 10.1371/journal.ppat.1000849.

19.

Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane.

Frieman M, Yount B, Heise M, Kopecky-Bromberg SA, Palese P, Baric RS.

J Virol. 2007 Sep;81(18):9812-24. Epub 2007 Jun 27.

20.

Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells.

Spiegel M, Schneider K, Weber F, Weidmann M, Hufert FT.

J Gen Virol. 2006 Jul;87(Pt 7):1953-60.

PMID:
16760397

Supplemental Content

Support Center